| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
25,717 |
20,365 |
$1.87M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
25,350 |
17,727 |
$1.18M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
8,750 |
6,508 |
$899K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
12,493 |
9,339 |
$854K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
16,091 |
11,345 |
$494K |
| 99051 |
|
20,034 |
17,132 |
$104K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,401 |
1,145 |
$34K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,695 |
1,600 |
$30K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,193 |
1,904 |
$19K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
707 |
461 |
$18K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
264 |
225 |
$14K |
| 36415 |
Collection of venous blood by venipuncture |
1,344 |
1,111 |
$3K |
| 81025 |
|
661 |
511 |
$3K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
97 |
88 |
$3K |
| 99385 |
|
17 |
12 |
$1K |
| 99173 |
|
186 |
163 |
$1K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
51 |
33 |
$965.12 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
51 |
33 |
$965.12 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
59 |
45 |
$789.49 |
| 92552 |
|
66 |
54 |
$598.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
94 |
84 |
$581.10 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
78 |
69 |
$579.18 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
14 |
13 |
$361.92 |
| 36416 |
|
140 |
122 |
$349.65 |
| 71046 |
Radiologic examination, chest; 2 views |
16 |
14 |
$245.00 |
| 93000 |
|
16 |
16 |
$229.92 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
17 |
16 |
$184.80 |
| 94760 |
|
79 |
71 |
$84.93 |
| 99000 |
|
17,144 |
14,218 |
$54.91 |
| 83986 |
|
14 |
14 |
$43.12 |
| 81002 |
|
1,724 |
1,144 |
$35.86 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
59 |
56 |
$14.44 |
| 99072 |
|
3,456 |
2,986 |
$0.00 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
455 |
422 |
$0.00 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
36 |
31 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
81 |
66 |
$0.00 |
| 85018 |
|
111 |
95 |
$0.00 |
| 90686 |
|
44 |
43 |
$0.00 |
| A9150 |
Non-prescription drugs |
15 |
12 |
$0.00 |